Sabra (SBRA) Director Catherine Cusack Receives 791 Stock Units

What Happened
Catherine Cusack, a director of Sabra Health Care REIT, Inc. (SBRA), was credited with 791 stock units on August 31, 2026 as an award/dividend-equivalent payment (Transaction code: A). The units were issued at $0.00 per unit (total reported value $0) and are dividend equivalents tied to previously granted stock units under Sabra’s 2009 Performance Incentive Plan. These credited units will vest and be payable on the same terms as the original underlying stock units.

Key Details

• Transaction date and terms: 2026-08-31 — 791 stock units credited, $0.00 per unit (award/dividend-equivalent).
• Ownership details reported: filing notes 7,027 unvested stock units and 47,553 vested but deferred stock units (each unit equals the right to one share). The 791 units are dividend-equivalent credits related to those outstanding awards.
• Footnotes: F1 explains these are dividend-equivalent stock units that follow the vesting/payment terms of the original awards; F2 breaks out unvested vs. vested-but-deferred units.
• Timeliness: Form 4 was filed 2026-09-02 for an 2026-08-31 transaction; this filing is within the usual two-business-day reporting window (timely).

Context
This was not a market purchase or sale but a routine compensation-related credit (dividend equivalents) tied to existing equity awards. Such credits are common for directors and reflect plan mechanics rather than a direct buy/sell signal about the director’s view of the company.